Reactive oxygen species (ROS) contribute to the ischemia-reperfusion injury. In kidney, the intracellular sources of ROS during ischemia-reperfusion are still unclear. In the present study, we investigated the role of the catecholamine-degrading enzyme monoamine oxidases (MAOs) in hydrogen peroxide (H 2 O 2 ) generation after reperfusion and their involvement in cell events leading to tissue injury and recovery. In a rat model of renal ischemia-reperfusion, we show concomitant MAO-dependent H 2 O 2 production and lipid peroxidation in the early reperfusion period. Rat pretreatment with the irreversible MAO inhibitor pargyline resulted in the following: i) prevented H 2 O 2 production and lipid peroxidation; ii) decreased tubular cell apoptosis and necrosis, measured by TUNEL staining and histomorphological criteria; and iii) increased tubular cell proliferation as determined by proliferating cell nuclear antigen expression. MAO inhibition also prevented Jun N-terminal kinase phosphorylation and promoted extracellular signal-regulated kinase activation, two mitogen-activated protein kinases described as a part of a "death" and "survival" pathway after ischemia-reperfusion. This work demonstrates the crucial role of MAOs in mediating the production of injurious ROS, which contribute to acute apoptotic and necrotic cell death induced by renal ischemia-reperfusion in vivo. Targeted inhibition of these oxidases could provide a new avenue for therapy to prevent renal damage and promote renal recovery after ischemia-reperfusion.
Several studies have described some of the molecular and cellular mechanisms responsible for the progression of ARF supplying the basis for its prevention and therapy of this renal disease. It has long been recognized that necrosis is a major form of cell death-associated ARF. However, since the first studies documenting the occurrence of apoptosis in ARF (1) , there is accumulating evidence that indicates a role of apoptotic pathways in I/R injury (1) (2) (3) . In contrast to other organs, where ischemia leads to irreversible tissue necrosis, in kidney surviving tubular cells can proliferate and differentiate after acute renal injury (4) . Thus, recovery of renal structure and function from ARF depends not only on minimizing cell death, but also on the replacement or regeneration of cells lost by death or desquamation.
The intracellular events involved in cell apoptosis, necrosis, and survival after I/R are not completely established. Nevertheless, possible candidates include the mitogen-activated protein kinases (MAPK). Indeed, it has been shown that activation of Jun N-terminal kinase (JNK) promotes apoptosis, whereas extracellular signal-regulated kinase (ERK) activation contributes to protection against cell injury (5) (6) (7) . In ischemic-reperfused organs, ERK, JNK, and p38 are often activated immediately after reperfusion. However, the pattern and the time course of their activation, as well as their respective involvement in cell apoptosis or recovery, appears to be tissue-specific (5, 8, 9) .
Several investigators have pointed out the involvement of reactive oxygen species (ROS) in MAPK activation (10, 11) , proliferation, or apoptosis, as well as in the pathogenesis of I/R injury. Indeed, it has been shown that I/R is associated with an increase in ROS production and lipid peroxidation (12) and a modification of the antioxidant mechanisms (13) . In addition, antioxidants and radical scavengers have proved their beneficial properties on I/R-mediated tissue injury (14) (15) (16) (17) . At present, the role of the different intracellular sources of ROS in I/R tissue injury remains uncertain. Previous works have shown that the mitochondrial electron transport chain (18) , NADPH-oxidase (19) , and xanthine oxidase (20) could be involved in ROS generation during reperfusion. However, it has been reported that I/R injury can occur in organs known to be deficient for xanthine-oxidase (21) and in a mouse model lacking a functional NADPH oxidase (22) . In addition, in kidney, the role of xanthine oxidase in I/R injury is still controversial (23) (24) (25) . Monoamine oxidases (MAOs: EC 1.4.3.4.) are another possible intracellular source of ROS. These enzymes are flavoproteins localized in the outer mitochondrial membrane that catalyze the oxidative deamination of neurotransmitters (i.e., noradrenaline, dopamine, and serotonin) and different exogenous and endogenous amines. The two isoenzymes MAO-A and -B are irreversibly and specifically inhibited by propargylamine derivatives, such as pargyline (26) . MAOs are distributed widely in various organs, and their modifications have been implicated in the development or the maintenance of psychiatric and neurodegenerative disorders. The H 2 O 2 generated by MAOs has been considered as a potential cytotoxic factor involved in the development of Parkinson's disease (27) . Furthermore, it has been suggested that MAOs could be involved in ROS production during I/R in the brain (28) (29) . Although the kidney is one of the organs expressing the highest amount of MAOs, the role of these enzymes on renal function and diseases has still not been fully elucidated. We have shown recently that MAO are an intracellular source of H 2 O 2 in intact renal mesangial and proximal tubule cells (30) . We also demonstrated a dual effect of H 2 O 2 generated by MAOs on proximal tubule cells: proliferative at low (31) and apoptotic at high (Bianchi, P. et al., unpublished observations) concentrations. In this report we investigated the role of MAOs on renal post-I/R cell events leading to tissue injury and recovery.
MATERIALS AND METHODS

Materials
Hank's balanced salt solution medium was from Gibco-BRL (Eragny, France), polyvinylidene difluoride (PVDF) membrane from NEN TM Life Science Products (Boston, MA), anti-active MAPK polyclonal antibody from Promega (Madison, WI), Kit ECL detector reagents from Amersham (Buckinghamshire, UK), anti-rabbit polyclonal IgG ERK2 from Santa Cruz Biotechnology (Santa Cruz, CA), and Bio-rad DC protein assay reagents were from Bio-rad Laboratories (Ivry-sur-Seine, France). Other chemicals were purchased from Sigma Chemical Co. (St. Louis, MO).
Animals
Male Sprague-Dawley rats weighing 140-190 g (Harlan ZI Du Malcourlet, France) were housed individually in standard laboratory cages with ad libitum access to food and water. Animal care complied with the Principles of Laboratory Animal Care formulated by the National Society for Medical Research and the Guide for the Care and Use of Laboratory Animals (National Institutes of Health publication 86-23, revised 1989, authorization 00577, 1989, Paris, France). The rats were anesthetized with sodium pentobarbital (60 mg/kg, intraperitoneally). The jugular vein was cannulated with a polyethylene catheter (PE-10) for the administration of drugs. Ischemia was induced by clamping of the right renal artery for 45 min by using a nontraumatic vascular clip. During the operation, the animals were kept on a surgical thermostatically controlled table at 38±1°C under anesthesia. After surgery, the animals were returned to the cages, where they had free access to food and water. The kidneys were removed at the end of the ischemic period and after 5 min, 15 min, 30 min, 1 h, 6 h, 24 h, 48 h, 72 h, and 7 days of reperfusion. After excision, the kidneys were divided lengthways into two parts: one was immediately frozen in liquid nitrogen for biochemical assays, and the other was fixed in Dubosc solution for histological examination. All frozen renal tissues were then kept at -80° C until further assay.
Experimental protocol
The rats were divided into five groups described in Table 1 . Saline or pargyline (6 mg/kg, i.v.) was administered 15 min before clamping the right renal artery for 45 min in groups 3 and 4, respectively. All drugs were administered in a volume of 100 µl/100 g of body weight. Shamoperated animals were subjected to the same surgical procedure without clamping the right renal artery 15 min after saline or pargyline treatment. In group 5, the pargyline was injected 1 h after I/R.
Monoamine Oxidase Assay
MAO-A activity was measured from renal cortex homogenates by a modification of the method of described in Ref. 32 . The reaction was terminated by the addition of 100 µl 4 M HCl at 4°C. The acid oxidation products were extracted by addition of 1 ml toluene-ethylacetate (1:1, v/v), and the radioactivity contained in the organic phase was analyzed by liquid scintillation spectrometry at 97% efficiency.
Luminol-amplified chemiluminescence assay
Hydrogen peroxide production was measured in the nonsonicated renal cortex homogenates by luminol-amplified chemiluminescence (CL) in the presence of luminol (30 µM) and peroxidase (0.1 U/ml), as described previously (30) . The assay is based on the principle that luminol, in the presence of one-electron oxidants, forms an excited aminophthalate ion that emits a photon when it returns to its ground state. The millivolts (mv) recorded by the luminometer are proportional to the chemiluminiscence produced in the samples. The generation of chemiluminescence triggered with 10 µM tyramine was continuously monitored for 60 min by using a thermostatically (37°C) controlled luminometer (Bio-Orbit 1251, Turku, Finland), and the area under the curve was analyzed by the Bio-Orbit MultiUse program.
Determination of malondialdehyde
Malondialdehyde (MDA) is an end-product of peroxidation of cell membrane lipids caused by oxygen-derived free radicals. It was assayed in renal tissue from the level of chromogen obtained from the reaction of MDA with 2-thiobarbituric acid according to Aruoma et al. (33) with some modifications. The kidneys obtained after 5 min of reperfusion were placed in 50 mM Tris-HCl (pH 7.4) containing 180 mM KCl and 10 mM ethylene diamine tetraacetate (EDTA) in a total volume of 2 ml and were homogenized. Briefly, 20 µl homogenate were added to 980 µl water, 100 µl HCl (0.5 M) and 1 ml 0.8% thiobarbituric acid. This solution was heated to 95°C for 20 min. After addition of 2 ml of butanol-1, the mixture was centrifuged at 2000 rpm for 10 min at 4°C. The absorbance of the upper layer was read at 548 nm (Spectrofluo JY3 D, Jobin Yvon, Paris, France). MDA bis-dimethyl acetal (Sigma) was used as the external standard. Results are expressed as nanomols MDA per milligram protein.
Histological examination
Dubosc-fixed and paraffin-embedded kidney specimens were stained with hematoxylin-eosin (5 µm). Histological changes were evaluated by measuring of tissue necrosis graded on a 0 to 5 scale in relation to the extent of kidney damage: 0 = none; 1 = up to10%; 2 = from 10 to 25%; 3 = from 25 to 50%; 4 = from 50 to 75%; 5 = more than 75%. Tubular necrosis was assessed at 24, 48, 72 h, and 7 days after I/R.
Evaluation of apoptosis
For immunohistochemistry, the sections of kidney embedded in paraffin were deparaffinized in toluene and a graded series of ethanol. DNA fragmentation was visualized in situ on fixed tissues by the TUNEL (terminal transferase-mediated dUTP nick-end labeling) procedure by using the apoptosis detection kit of Promega. Briefly, after rinsing, the deparaffinized sections were incubated in a 20 µg/ml proteinase K solution to permeabilize the tissues, rinsed, and fixed in 4% paraformaldehyde. The sections were incubated with 1 µl of terminal deoxynucleotidyl transferase (25 U/µl) and fluorescein-12-dUTP in equilibration buffer [25 mM Tris-HCl, pH 6.6; 200 mM potassium cacodylate, pH 6.6; 2.5 mM cobalt chloride; 0.25 mg/ml bovine serum albumin (BSA); 0.2 mM DL -dithiothreitol for 1 h at 37°C. Then after rinsing four times in salt sodium citrate and phosphate buffered saline (PBS), the slides were immersed in 40 ml propidium iodide solution (1 µg/µl) for 15 min. The positive control was treated by DNAse I (1 µg/µl) before being processed with the TUNEL procedure.
Proliferating cell nuclear antigen (PCNA) expression
PCNA was used as a marker for cell proliferation. Immunostaining was performed with streptavidin/biotin immunoperoxidase method (Zymed's PCNA Staining kit, Zymed Laboratories Inc., San Francisco, CA). The deparaffinized sections were immersed in 3% H 2 O 2 in methanol for 10 min to quench the endogenous peroxidase activity and was incubated further with biotinylated mouse PCNA at room temperature for 1 h. After being washed with PBS, the sections were incubated with peroxidase-labeled streptavidin for 10 min. Peroxidase staining was carried out using 3,3'-diaminobenzidine as the chromogen. Sections were counterstained using hematoxylin. The number of labeled nuclei per section was counted in the three most positive high-power fields (× 40), and the labeling index [labeled nuclei/total nuclei ×100 (%)] was calculated.
Western-blot analysis
Lysate samples (30 µg of protein/lane) from cortex homogenates were run in 10% SDS-PAGE and transferred onto PVDF membranes as described previously (34) . The membranes were blocked with 1% BSA in Tris[hydroxymethyl]amino-methane-HCl-Tween 20 (0.1%) (TBST) overnight at 4°C. We probed the immunoblots by using the following primary antibodies: 1) polyclonal rabbit anti-ACTIVE TM MAPK pAb, which recognizes the phosphorylated Thr 183 and Tyr 185 of 42-and 44-kDa ERK isoforms; or 2) polyclonal rabbit anti-ACTIVE TM JNK pAb (dilution 1:5000 for 2 h, room temperature). After being washed in TBST, membranes were incubated with horseradish peroxidase (HRP)-linked anti-rabbit IgG antibody (1:10,000, for 1 h, room temperature); bands were detected by using the ECL reaction. The anti-MAPK active blots were stripped completely of antibodies before reprobing with rabbit polyclonal anti-ERK2 or anti-JNK2 antibody.
Protein assay
We determined protein concentrations with the Bio-rad DC protein assay reagents (Bio-rad Laboratories), with γ globulins as standard.
Statistical analysis
The data are presented as mean ± SEM. We performed statistical analysis by using one-way ANOVA, followed by Newman-Keuls multiple comparisons. P<0.05 were considered statistically significant.
RESULTS
Renal MAO-A activity and MAO-dependent H 2 O 2 production during I/R: effect of pargyline treatment
Whereas MAO-A is the predominant isoenzyme expressed in different rat renal cell types (31, 35) , enzyme assays were performed by using the specific MAO-A substrate, [ 14 C] serotonin. As shown in Figures 1A and 1B , MAO-A activity and MAO-dependent H 2 O 2 production were strongly inhibited during ischemia and recovered to the control sham-operated values 5 min after reperfusion. Rat treatment with pargyline (6 mg/kg i.v, in a single injection 15 min before ischemia) inhibited both MAO activity and MAO-dependent H 2 O 2 production (Fig. 1A, B) , indicating that pharmacological MAO inhibition prevents H 2 O 2 generation in the early phases of reperfusion.
MAO inhibition prevents lipid peroxidation induced by I/R
To determine whether H 2 O 2 generation by MAOs participates in the oxidative stress during reperfusion, we measured the kidney levels with MDA, a marker of lipid peroxidation, MDA. As shown in Figure 2 , MDA increased after 5 min of reperfusion in saline-treated rats, as compared with sham-operated animals. Such an increase was transient, as it was not observed 1 h after reperfusion (data not shown). Pargyline treatment prevented the MDA increase, which suggests that MAO plays a critical role in oxidative stress.
Effect of pargyline treatment on tubular necrosis and apoptosis induced by I/R
Cell necrosis and apoptosis, which are highly dependent on ROS production, represent the major post-reperfusion events leading to renal injury. Histological evaluation of hematoxylin-and eosin-stained kidney sections indicated an absence of significant differences between shamoperated animals pretreated with saline or pargyline (Fig. 3) . In reperfused kidneys of salinetreated rats, extensive necrosis (grade 4-5 of the grading scale), mainly located at the proximal tubules, was evident after 24 h, 48 h, and 72 h of reperfusion in 19 out of 24 rats (Table 2) . Normal renal morphology was not recovered completely 1 week after I/R. Pretreatment with pargyline 15 min before ischemia significantly reduced the degree of tubular necrosis observed after 24 h to 72 h of reperfusion ( Figure 3 and Table 2 ). This protective effect was evident only when pargyline was administered before ischemia. Indeed, when pargyline was administered after 1 h of reperfusion, 7 out of 8 animals presented grade 4 or 5 of necrosis (data not shown).
Cell apoptosis was evaluated by TUNEL immunostaining to localize DNA fragmentation and by morphological analysis. As shown in Figures 4A and B , the number of tubular epithelial cells containing TUNEL-positive nuclei increased after 6 and 24 h of reperfusion compared with the sham-operated controls. In contrast, cell staining in pargyline treated rats (P+I/R) did not differ from that observed in sham-operated rats untreated (S) or treated (P) by pargyline. The typical morphological features of apoptosis such as chromatin and cytoplasmic condensation are depicted in Figure 4C .
Effect of pargyline treatment on renal cell proliferation after I/R
To investigate whether, in addition to controlling cell death processes, MAO inhibition promotes cell regeneration, we evaluated PCNA expression in kidney sections from the different groups of rats. As previously shown (36) , renal PCNA expression increased 2 and 3 days after I/R compared with kidneys from sham-operated rats. Pargyline treatment did not modify PCNA staining in sham-operated rats. In contrast, it significantly increased the number of PCNApositive nuclei in proximal tubules at 6 h, 48 h, and 72 h after I/R as compared to untreated rats (Fig. 5) .
Taken together, these data indicate that MAO inhibition promotes the tubular cell proliferation involved in the recovery of renal structure after I/R.
Effect of pargyline treatment on MAPK activation after I/R
To determine the mechanisms involved in both promotion of regeneration and controlling cell death processes by MAO inhibition, we examined the activity of MAPKs after I/R. We studied ERKs and JNKs, which have been described in ischemia and reperfusion injury as being part of a "survival" and "death" pathway, respectively (37) . As shown in Figure 6 , the Thr/Tyr phosphorylation status of ERKs and JNKs, corresponding to the activated forms of these enzymes, were faintly detectable in sham-operated rats. ERK1/ERK2 phosphorylation remained weak after 6 h and 24 h of reperfusion, whereas JNK2 phosphorylation strongly increased. Pargyline treatment reversed JNKs phosphorylation and caused ERK1/ERK2 activation, which indicates that MAO inhibition can regulate the balance of ERK/JNK activities.
DISCUSSION
The extent of renal necrosis and the time required for tissue regeneration are major determinants of the prognosis of renal failure after I/R. In this study, we show that both post-reperfusion renal injury and regeneration are both strongly dependent on MAO activity. Indeed, inhibition of renal MAO by pargyline administration before ischemia significantly reduces renal oxidative stress, JNK activation, apoptosis and necrosis induced by reperfusion and increases ERK activation, and tubular cell proliferation. These effects were not observed when pargyline was administered 1 h after the beginning of reperfusion, which suggests the critical role of MAO in the initiation of renal cell injury.
These results provide new insights into the function of MAOs in kidney. Indeed, to date, renal MAOs were considered exclusively as factors regulating the availability of their substrates, particularly dopamine and serotonin (38, 39) , and their effects on sodium excretion. According to our recent in vitro findings, the results of the present study suggest that MAO may regulate additional renal functions through ROS production. The excessive formation of ROS causes lipid peroxidation of cell membranes (40) , protein and enzyme oxidation (41) , and some irreversible DNA changes (42) leading to inactivation of key cellular functions and ultimately to cell death. In kidney, the sources of ROS during reperfusion and their impact on tissue injury and recovery are still ill-defined. Our results showing that post-reperfusion H 2 O 2 production and lipid peroxidation were fully prevented by pargyline treatment indicate that, in kidney, i) MAOs are a major source of H 2 O 2 in the early phases of reperfusion, and ii) MAO-dependent H 2 O 2 production is responsible for the post-reperfusion oxidative stress. The large impact of H 2 O 2 produced by MAOs on renal apoptosis and necrosis may be related to the regional distribution and subcellular location of these enzymes. Indeed, MAO expression is particularly high in the proximal tubule cells, which not only produce large amount of ROS during reperfusion (43) but also are the major target of reperfusion injury mediated by ROS (44, 45) . In addition, proximal tubules produce, and therefore contain, most of the renal dopamine and serotonin-two MAO substrates. We have found that serotonin and dopamine concentrations were increased significantly in the early phase of reperfusion (Kunduzova, O. et al., unpublished observations). It is conceivable that, acting together, the high MAO expression and the elevated substrate concentration, may promote the production of large amounts of H 2 O 2 in proximal tubules during the reperfusion. The subcellular location of MAOs at the outer mitochondrial membrane is an additional factor that may explain the importance of these enzymes in the induction of cell apoptosis. It has been shown extensively that mitochondria play a key role in apoptosis by the production of ROS and the release of apoptotic factors such as Cytochrome c, apoptosis-inducing factor, and calcium (46) (47) (48) . In addition, the series of results obtained in vitro suggested that mitochondrial dysfunction and cell apoptosis can be induced by MAO-dependent H 2 O 2 production. Indeed, it has been shown that H 2 O 2 production by MAO, which can be higher than that generated by the impaired mitochondrial respiratory chain (49), results in the increases the intramitochondrial formation of oxidized glutathione (50, 51) , enhances mitochondrial Ca 2+ efflux (51), reduces mitochondrial electron transport, (52) and causes oxidative damage to mitochondrial DNA (53) . According to these results, it has been reported that MAO inhibitors, such as pargyline or clorgyline, prevent the apoptosis of human melanoma M14 (54), PC12 (55) , and rat renal proximal tubule cells (Bianchi P. et al., unpublished observations). As observed in vitro, the production of H 2 O 2 by MAOs at the outer mitochondrial membrane may accelerate the mitochondrial processes responsible for apoptosis observed after I/R.
Many studies have shown that MAPK activation plays a critical role in post-I/R cell events. JNKs have been implicated recently in mitochondrial death (56) , and the activation of the JNK cascade is considered as an important intermediate of cell apoptosis (9, 57) As previously reported (5), we show here that post-reperfusion tubular cell apoptosis is associated with strong JNK activation. The fact that MAO inhibition prevents JNK phosphorylation suggests that the activation of this MAPK participates as one of the intermediate steps between H 2 O 2 production by MAOs and apoptosis after I/R. Because ROS could be upstream of MAPK activation, we can speculate that pargyline decreases post-reperfusion MAO-dependent H 2 O 2 production and in turn limits the oxidative stress responsible for the initiation of the intracellular machinery leading to tubule injury.
MAO inhibition also modified the activation of ERKs, another member of the MAPK family. Indeed, in contrast to what is observed for JNK, pargyline administration induced a significant increase in ERK phosphorylation. ERKs have been implicated in protection against cell injury (58) , and their activation has been considered to be a sign of renal regeneration and protection (57, 59) . In agreement with these results, we found that the increase in ERK activation following MAO inhibition was associated with accelerated tubule cell proliferation and recovery of normal renal morphology. Therefore, the beneficial effects of MAO inhibition on post I/R renal injury may be related, in part, to the inversion of the JNK-ERK activation ratio.
Although irreversible MAO inhibitors have been considered as potent antidepressive drugs, their use has been limited by important side effects occurring during chronic administration. Our demonstration that a single injection of pargyline is sufficient to decrease post-I/R renal injury and to accelerate tubule regeneration opens new perspectives for the therapy of post-I/R renal failure, which is one of the major complications of kidney transplantation and angioplasty of renal artery. Clinical studies will be necessary to evaluate the therapeutic properties of irreversible MAO inhibitors in post-I/R syndromes, not only in kidney but also in heart and brain-two organs containing a large amount of MAOs. Sham-operated and ischemic groups of rats were treated with saline or pargyline (6 mg/kg, i.v.) 15 min before 45 min of unilateral ischemia. A) MAO-A activity was measured by using [ 14 C] serotonin as substrate in renal cortex homogenates. B) MAO-dependent H 2 O 2 production was determined by luminolamplified chemiluminescence (CL) assay as described in Materials and Methods. The total chemiluminescence emission (area under the curve) was monitored for 60 min after tyramine (10 µM) addition to the same homogenates. Data represent mean values ± SE of six experiments.
* P < 0.001 versus sham group. S: sham-operated rats treated with saline; P: sham-operated rats treated with pargyline; I: rats subjected to ischemia; I/R5: rats subjected to ischemia followed by 5 min of reperfusion; P+I/R5: rats treated with pargyline before ischemia followed by 5 min of reperfusion. Rats were killed 5 min after reperfusion. S: sham-operated rats treated with saline; I/R: rats subjected to ischemia followed by reperfusion; P+I/R: rats treated with pargyline before ischemia followed by reperfusion. Data are expressed as the mean ± SEM from four separate experiments.
* P < 0.01 vs. sham group. Data shown are mean ± SEM of four independent experiments quantified in triplicate. * P < 0.001 vs. sham group; # P < 0.001 vs. ischemic group. C) Representative light micrographs (magnification, ×100) of hematoxilin and eosin stained sections showing morphologic features of tubule cells after 6 h of reperfusion. S: sham-operated rats treated with saline; P: sham-operated rats treated with pargyline; I/R: rats subjected to ischemia followed by reperfusion; P+I/R: rats treated with pargyline before ischemia followed by reperfusion. * P<0.001 vs. sham group; # P<0.001 versus ischemic group. S: sham-operated rats treated with saline; P: sham-operated rats treated with pargyline; I/R: rats subjected to ischemia followed by reperfusion; P+I/R: rats treated with pargyline before ischemia followed by reperfusion. Kidneys from sham-operated rats treated with saline (S) or pargyline (P) and ischemic kidneys from rats treated with saline (I/R) or pargyline 15 min before ischemia (P+I/R) were removed after 6 and 24 h of reperfusion. ERK and JNK activation were revealed in whole tissue lysates by Western blot analysis by using anti-phospho-ERK (p-ERK) and phospho-JNK (p-JNK) antibodies. The same membranes were stripped and reblotted with ERK-2 and JNK-2 antibodies to evaluate the total amount of ERK and JNK. The blots are representative of the results obtained from four animals.
